Mind Medicine MindMed Inc Equity-NMS: MNMD

$5.43 -0.12 (April 5, 2025)

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Previous close :$5.55
Open :$5.24
Today's high :$5.55
Today's low :$4.93
52W low :$4.93
52W high :$11.36
EPS(TTM): :-1.54
Shares O/S :75.37 M
Market cap :409.25 M

Compare with Other Stocks

Stocks Price 1D PE Market Cap
Mind Medicine MindMed Inc $5.43 +0% - 409.25M

Frequently Asked Questions

What is the share price of Mind Medicine MindMed Inc today?

Mind Medicine MindMed Inc (MNMD) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

About Mind Medicine MindMed Inc

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).